School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Pelthos Therapeutics Inc. PTHS

Healthcare · Biotechnology

$20.50last close 2026-10-09 · market cap $78.48M · delayed data

Trailing returns

1M-12.47%
3M-24.52%
6M-9.21%
1Y-18.00%

Basis: Adjusted daily closes.

What it does

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.

Open PTHS in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies